Related Experiment Video
Updated: Jun 10, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Incidence of common cancers in Georgia in 2015-2019: A national cancer registry study
Ani Beraia1, Ariana Znaor2, Erik Eik Anda3
1Department of Community Medicine, UiT-The Arctic University of Norway, Tromsø, Norway; Department of Medical Statistics, National Center for Disease Control and Public Health, Tbilisi, Georgia.
Background:
Cancer is the second leading cause of death worldwide, including in Georgia. This study aimed to evaluate the number of new cancer cases, identify the most common cancer sites, analyze sex differences, and evaluate age-standardized rates (ASR) and age-specific rates from 2015 to 2019 in Georgia.
Methods:
We used the Georgia National Cancer Registry data for all registered cancer cases, excluding non-melanoma of skin, and the National Statistics Office of Georgia population data. ASRs per 100,000 population were calculated using the direct standardization method, with the WHO's world standard population as a reference.
Results:
Between 2015 and 2019, 50,098 cancer cases (ICD-10 codes C00-96 exc. C44) were diagnosed in Georgia, including 21,802 in men (ASR 175.5/100,000) and 28,296 in women (ASR 192.8/100,000). Among men, the most common cancer sites were lung (16%, ASR 28.0/100,000); prostate (14%, ASR 22.0/100,000); bladder (10%, ASR 16.3/100,000); colorectal (10%, ASR 16.2/100,0000); and larynx (6%, ASR 10.9/100,000). Among women, the most common cancer sites were breast (34%, ASR 64.5/100,000), thyroid (14%, ASR 34.3/100,000), colorectal (7%, 10.3/100,000), cervix (6%, ASR 12.6/100,000) and corpus uteri (6%, ASR 11.4/100,000), respectively.
Conclusion:
This is the first comprehensive evaluation of cancer incidence in Georgia. Beyond sex-specific cancers such as breast and prostate, lung cancer was more common in men, while thyroid cancer was more common in women. The overall cancer incidence in Georgia was lower than the 2022 GLOBOCAN-estimated ASR for the 27 EU countries. Differences in healthcare infrastructure, screening uptake, or reporting accuracy may explain these disparities.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Survival Analysis
